More importantly, it was the neutrophils (CD11b+CD15+ cells) in the TME that expressed more CD71 (Figure S2, Supporting Information), suggesting neutrophil ferroptosis as a potential therapeutic target for GC. The gene discussed is TFRC; the disease is gastric cancer.